Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Day One Biopharmaceuticals Inc shares valued at $52,278 were sold by York Charles N II on Feb 18 ’25. At $11.96 per share, York Charles N II sold 4,370 shares. The insider’s holdings dropped to 252,638 shares worth approximately $2.0 million following the completion of this transaction.
Also, Dubow Adam sold 4,646 shares, netting a total of over 55,580 in proceeds. Following the sale of shares at $11.96 each, the insider now holds 39,602 shares.
Before that, Bender Jeremy had sold 12,048 shares from its account. In a trade valued at $144,130, the CHIEF EXECUTIVE OFFICER traded Day One Biopharmaceuticals Inc shares for $11.96 each. Upon closing the transaction, the insider’s holdings decreased to 12,048 shares, worth approximately $1.01 million.
As published in a research note from Needham on October 09, 2024, Day One Biopharmaceuticals Inc [DAWN] has been retained to a Buy and the price target has been revised to $33. Analysts at BofA Securities upgraded the stock from ‘”an Underperform”‘ to ‘”a Buy”‘ outlook in a report released in early August. As of April 24, 2024, Needham has reiterated its “Buy” rating for DAWN. Earlier on April 25, 2023, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for DAWN stock which previously was a “a Buy”.
Analyzing DAWN Stock Performance
During the last five days, there has been a surge of approximately 16.86%. Over the course of the year, Day One Biopharmaceuticals Inc shares have dropped approximately -37.65%. Shares of the company reached a 52-week high of $13.53 on 01/28/25 and a 52-week low of $6.41 on 04/09/25. A 50-day SMA is recorded $8.76, while a 200-day SMA reached $12.52.
Support And Resistance Levels for Day One Biopharmaceuticals Inc (DAWN)
According to the 24-hour chart, there is a support level at 7.53, which, if violated, would cause prices to drop to 7.16. In the upper region, resistance lies at 8.09. The next price resistance is at 8.28. RSI (Relative Strength Index) is 51.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.42, which suggests the price will decrease in the coming days. Percent R is at 0.67%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
